Zymeworks Inc.

ZYME

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001937653

SEC filings (opens in a new tab)

No open-market purchases or sales by Zymeworks Inc. insiders were filed in the last 90 days; 202 institutions reported holding it in 13F filings for Q2 2026, worth $1.79B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Zymeworks Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of ZYME: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	164	2	163	+1
Shares	68.2M	4.25M	66.6M	+2.61M (+4.1%)
Value	$580.6M	$36.2M	$834.7M	+$290.3M (+53.3%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Zymeworks Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to ZYME in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	4,263,595	$53.5M	0.00%
Nextech Invest AG	1,113,946	$14.0M	1.96%
Arrowstreet Capital, Limited Partnership	407,771	$5.12M	0.00%
Assenagon Asset Management S.A.	331,144	$4.16M	0.01%
Marshall Wace, LLP	209,765	$2.63M	0.00%
Panagora Asset Management Inc	100,866	$1.27M	0.01%
Deerfield Management Company, L.P. (Series C)	49,546	$621.8K	0.01%
HRT Financial LP	48,808	$612.0K	0.00%
Caxton Associates LP	45,810	$574.9K	0.03%
Group One Trading, L.P.	29,841	$374.5K	0.01%
Blackstone Group Inc.	25,082	$314.8K	0.00%
Intech Investment Management LLC	21,160	$265.6K	0.00%
Fox Run Management, L.L.C.	16,465	$206.6K	0.05%
Shell Asset Management Co	12,357	$155.0K	0.01%
Lazard Asset Management LLC	9,561	$119.0K	0.00%
nVerses Capital, LLC	6,300	$79.1K	0.04%
DekaBank Deutsche Girozentrale	3,843	$47.0K	0.00%
Aster Capital Management (DIFC) Ltd	756	$9.49K	0.00%
Credit Agricole S A	75,000	$9.41K	0.00%
Truvestments Capital LLC	259	$3.25K	0.00%
Sterling Capital Management LLC	195	$2.45K	0.00%
Cornerstone Planning Group LLC	161	$2.21K	0.00%
Smartleaf Asset Management LLC	142	$1.76K	0.00%
WR Wealth Planners, LLC	28	$351	0.00%
Capital Performance Advisors LLP	15	$188	0.00%
The PNC Financial Services Group, Inc.	4	$50	0.00%

Sold out (25)

Institutions that held Zymeworks Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of ZYME in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Sio Capital Management, LLC	491,128	$4.18M
Tejara Capital Ltd	270,212	$2.30M
Affinity Asset Advisors, LLC	191,127	$1.63M
Qube Research & Technologies Ltd	101,398	$862.9K
SummerHaven Investment Management, LLC	90,158	$767.2K
STRS Ohio	60,600	$515.7K
Jump Financial, LLC	45,769	$389.5K
Prudential Financial Inc	43,160	$367.3K
Marex Group plc	40,000	$340.4K
Pennant Investors, LP	38,700	$329.3K
Alps Advisors Inc	31,277	$266.2K
Principal Financial Group Inc	30,642	$260.8K
Campbell & CO Investment Adviser LLC	30,363	$258.4K
Walleye Capital LLC	26,374	$224.4K
Castleview Partners, LLC	15,219	$129.5K
CAPROCK Group, Inc.	15,112	$128.6K
XTX Topco Ltd	14,272	$121.5K
MQS Management LLC	10,790	$91.8K
State of Wyoming	4,099	$34.9K
AlphaMark Advisors, LLC	3,758	$32.0K
Point72 Asia (Singapore) Pte. Ltd.	914	$7.78K
Global Retirement Partners, LLC	905	$7.70K
Cypress Capital, LLC	237	$2.02K
Leonteq Securities AG	200	$1.70K
Toronto Dominion Bank	16	$136

Not filed for Q3 2024 yet (2)

Institutions that held Zymeworks Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ZYME in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	4,193,576	$35.7M
Susquehanna Fundamental Investments, LLC	59,523	$506.5K